Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors

被引：104

作者：

Ramajayam, R. ^{[1
]}

Tan, Kian-Pin ^{[2
]}

Liu, Hun-Ge ^{[2
]}

Liang, Po-Huang ^{[1
,2
]}

机构：

[1] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan

[2] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2010年 / 18卷 / 22期

关键词：

Pyrazolone; 3CL protease; SARS-CoV; Coxsackievirus; Computer modeling; RESPIRATORY SYNDROME CORONAVIRUS; 3CL PROTEASE; MAIN PROTEASE; POTENT INHIBITORS; DESIGN; MCI-186; IDENTIFICATION; CINANSERIN; PROTEINASE; ISCHEMIA;

D O I：

10.1016/j.bmc.2010.09.050

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A series of pyrazolone compounds as possible SARS-CoV 3CL protease inhibitors were designed, synthesized, and evaluated by in vitro protease assay using fluorogenic substrate peptide in which several showed potent inhibition against the 3CL protease. Interestingly, one of the inhibitors was also active against 3C protease from coxsackievirus B3. These inhibitors could be potentially developed into anti-coronaviral and anti-picornaviral agents. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：7849 / 7854

页数：6

共 50 条

[1] Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors
Zhou, Lu
Liu, Ying
Zhang, Weilin
Wei, Ping
Huang, Changkang
Pei, Jianfeng
Yuan, Yaxia
Lai, Luhua
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) : 3440 - 3443
[2] Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease
Amblard, Franck
Lecher, Julia C.
De, Ramyani
Zhou, Shaoman
Liu, Peng
Goh, Shu Ling
Tao, Sijia
Patel, Dharmeshkumar
Downs-Bowen, Jessica
Zandi, Keivan
Zhang, Huanchun
Chaudhry, Gitika
McBrayer, Tamara
Muczynski, Michael
Al-Homoudi, Abdullah
Engel, Joseph
Lan, Shuiyun
Sarafianos, Stefan G.
Kovari, Ladislau C.
Schinazi, Raymond F.
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 268
[3] QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors
Ishola, Ahmed Adebayo
Adedirin, Oluwaseye
Joshi, Tanuja
Chandra, Subhash
[J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 134
[4] Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
Grum-Tokars, Valerie
Ratia, Kiira
Begaye, Adrian
Baker, Susan C.
Mesecar, Andrew D.
[J]. VIRUS RESEARCH, 2008, 133 (01) : 63 - 73
[5] Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2
Yan, Yong
Liu, Hanwen
Wu, Di
Gu, Zhihao
Guo, Wenhao
Yao, Hequan
Lin, Kejiang
Li, Xuanyi
[J]. FUTURE MEDICINAL CHEMISTRY, 2024, 16 (09) : 887 - 903
[6] Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors
Kumar, Vathan
Tan, Kian-Pin
Wang, Ying-Ming
Lin, Sheng-Wei
Liang, Po-Huang
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (13) : 3035 - 3042
[7] Inhibition of SARS Coronavirus 3C-Like Protease by Isatis indigotica Root and Plant-derived Phenolic Compounds
Lin, Cheng-Wen
Tsai, Fuu-Jen
Tsai, Chang-Hai
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S79 - S79
[8] Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease
Li, Qingxin
Kang, CongBao
[J]. MICROORGANISMS, 2020, 8 (08) : 1 - 18
[9] Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors
He, Jun
Hu, Lijun
Huang, Xiaojun
Wang, Chenran
Zhang, Zhimin
Wang, Ying
Zhang, Dongmei
Ye, Wencai
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (02)
[10] Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases
Kumari, Madhulata
Subbarao, Naidu
[J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 132

← 1 2 3 4 5 →